Structure of a cannabinoid receptor and functional expression of the cloned cDNA
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Matsuda et al, 1990
In the citing paper
“Cannabinoids, like many analgesics and recreational drugs, act on the brain’s reward pathways. Cannabinoid-1 receptors (CB1R) are co-localized with the opioid receptors on the dopaminergic cells of the nucleus accumbens, probably the most important structure in human reward pathways, which partly overlaps the antinociceptive pathways [30–32].”
From Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial (2012) · cites this paper as [30]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [2]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
G proteins and dual control of adenylate cyclase
Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90336-2 · Cited by 1,802
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427
Self-citationA cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.
Okayama, H., & Berg, P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.2.280 · Cited by 933
Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family
McFarland, K. C., Sprengel, R., Phillips, H. S., Köhler, M., Rosemblit, N., Nikolics, K., Segaloff, D. L., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2502842 · Cited by 929
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Self-citationcDNA eloping of bovine substance-K receptor through oocyte expression system
Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., & Nakanishi, S. (1987) · Nature · doi:10.1038/329836a0 · Cited by 742
Cloning and Sequencing of Porcine LH-hCG Receptor cDNA: Variants Lacking Transmembrane Domain
Loosfelt, H., Misrahi, M., Atger, M., Salesse, R., Vu Hai-Luu Thi, M. T., Jolivet, A., Guiochon-Mantel, A., Sar, S., Jallal, B., Garnier, J., et al. (1989) · Science · doi:10.1126/science.2502844 · Cited by 559
Research works printed but not linked: 14
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Howlett, A. C. Molec. Pharmacol. 27, 429–436 (1985).
- Howlett, A. C. & Fleming, R. M. Molec. Pharmacol. 26, 532–538 (1984).
- Howlett, A. C., Qualy, J. M. & Khachatrian, L. L. Molec. Pharmacol. 29, 307–313 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. Molec. Pharmacol. 33, 297–302 (1988).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Lawrence, D. K. & Gill, E. W. Molec. Pharmacol. 11, 595–602 (1975).
- Hillard, C. J., Harris, R. A. & Bloom, A. S. J. Pharmac. exp. Ther. 232, 579–588 (1985).
- Okayama, H. & Berg, P. Molec. cell. Biol. 3, 280–289 (1983).
- Chen, C. & Okayama, H. Molec. cell. Biol. 7, 2745–2752 (1987).
- Brooker, G., Harper, J. F., Terasaki, W. L. & Moylan, R. D. Adv. Cyclic Nucleotide Res. 10, 1–33 (1979).
Cited by
Items 501–600 of 1,050
Stefano, G. B., Liu, Y., & Goligorsky, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19238 · Cited by 185
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S.-J., & Mackie, K. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 174
Endocannabinoids in the central nervous system-an overview
Fride, E. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0360 · Cited by 185
Cannabis use for chronic non-cancer pain: results of a prospective survey
Ware, M. A., Doyle, C. R., Woods, R., Lynch, M. E., & Clark, A. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00400-1 · Cited by 185
Addictive drugs and their relationship with infectious diseases
Friedman, H., Pross, S., & Klein, T. W. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00097.x · Cited by 188
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J.-A. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180
The expression of receptors for endocannabinoids in human and rodent skeletal muscle
Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Janovská, A., Game, P., & Wittert, G. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.099 · Cited by 177
Cianchi, F., Papucci, L., Schiavone, N., Lulli, M., Magnelli, L., Vinci, M. C., Messerini, L., Manera, C., Ronconi, E., Romagnani, P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0799 · Cited by 181
Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats
Muñoz-Luque, J., Ros, J., Fernández-Varo, G., Tugues, S., Morales-Ruiz, M., Alvarez, C. E., Friedman, S. L., Arroyo, V., & Jiménez, W. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131896 · Cited by 180
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
Berry, E. M., & Mechoulam, R. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00257-7 · Cited by 184
Schwarz, H., Blanco, F. J., & Lotz, M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90152-x · Cited by 180
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Waldeck-Weiermair, M., Zoratti, C., Osibow, K., Balenga, N., Goessnitzer, E., Waldhoer, M., Malli, R., & Graier, W. F. (2008) · Journal of Cell Science · doi:10.1242/jcs.020958 · Cited by 177
Solinas, M., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300720 · Cited by 174
Endocannabinoids as physiological regulators of colonic propulsion in mice
Pinto, L., Izzo, A. A., Mascolo, N., Capasso, F., Cascio, M. G., Bisogno, T., Di Marzo, V., Hospodar–Scott, K., & Brown, D. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34242 · Cited by 180
Miller, L. K., & Devi, L. A. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003491 · Cited by 177
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
Pacher, P., & Kecskemeti, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455594 · Cited by 175
Breivogel, C. S., Selley, D. E., & Childers, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16865 · Cited by 185
Cannabinoid Receptor Modulation of Synapses Received by Cerebellar Purkinje Cells
Takahashi, K. A., & Linden, D. J. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.3.1167 · Cited by 177
Wagner, J. A., Járai, Z., Bátkai, S., & Kunos, G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01112-8 · Cited by 177
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.011 · Cited by 171
The evolution and comparative neurobiology of endocannabinoid signalling
Elphick, M. R. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0394 · Cited by 171
Preet, A., Ganju, R. K., & Groopman, J. E. (2008) · Oncogene · doi:10.1038/sj.onc.1210641 · Cited by 172
Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
Seierstad, M., & Breitenbucher, J. G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800311k · Cited by 179
Rockwell, C. E., Snider, N. T., Thompson, J. T., Vanden Heuvel, J. P., & Kaminski, N. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019117 · Cited by 176
Valjent, E., Pagès, C., Rogard, M., Besson, M., Maldonado, R., & Caboche, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01652.x · Cited by 168
Henry, D. J., & Chavkin, C. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11289-9 · Cited by 173
Nackley, A. G., Makriyannis, A., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00126-x · Cited by 174
Yoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01690.2002 · Cited by 179
Cannabinoid ligand-receptor signaling in the mouse uterus.
Das, S. K., Paria, B. C., Chakraborty, I., & Dey, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4332 · Cited by 179
Carayon, P., Marchand, J., Dussossoy, D., Derocq, J.-M., Jbilo, O., Bord, A., Bouaboula, M., Galiègue, S., Mondière, P., Pénarier, G., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3605 · Cited by 178
Kimball, E. S., Schneider, C. R., Wallace, N. H., & Hornby, P. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2005 · Cited by 172
Oviedo, A., Glowa, J., & Herkenham, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 179
Moreira, F. A., & Wotjak, C. T. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_16 · Cited by 177
Bridges, D., Rice, A. S. C., Egertová, M., Elphick, M. R., Winter, J., & Michael, G. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00200-8 · Cited by 172
Richfield, E. K., & Herkenham, M. (1994) · Annals of Neurology · doi:10.1002/ana.410360406 · Cited by 177
Walker, J. M., & Huang, S. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00252-8 · Cited by 176
Endocannabinoid signalling: has it got rhythm?
Vaughn, L. K., Denning, G., Stuhr, K. L., de Wit, H., Hill, M. N., & Hillard, C. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00790.x · Cited by 176
Horswill, J. G., Bali, U., Shaaban, S., Keily, J. F., Jeevaratnam, P., Babbs, A. J., Reynet, C., & Wong Kai In, P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707347 · Cited by 175
Structural Basis for Human Monoglyceride Lipase Inhibition
Bertrand, T., Augé, F., Houtmann, J., Rak, A., Vallée, F., Mikol, V., Berne, P. F., Michot, N., Cheuret, D., Hoornaert, C., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.11.060 · Cited by 168
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 173
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi-Carmona, M., Shire, D., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 175
Effects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Bauer, M., Chicca, A., Tamborrini, M., Eisen, D., Lerner, R., Lutz, B., Poetz, O., Pluschke, G., & Gertsch, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382481 · Cited by 168
De Fonseca, F. R., Gorriti, M. A., Fernández-Ruiz, J. J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Sullivan, J. M. (2000) · Learning & Memory · doi:10.1101/lm.7.3.132 · Cited by 173
Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
STEINER, M., & WOTJAK, C. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00433-0 · Cited by 167
Regulation of food intake by oleoylethanolamide
Lo Verme, J., Gaetani, S., Fu, J., Oveisi, F., Burton, K., & Piomelli, D. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4494-0 · Cited by 169
Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes
Roche, R., Hoareau, L., Bes-Houtmann, S., Gonthier, M.-P., Laborde, C., Baron, J.-F., Haffaf, Y., Cesari, M., & Festy, F. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0127-4 · Cited by 166
Berrendero, F., García-Gil, L., Hernández, M. L., Romero, J., Cebeira, M., Miguel, R. D., Ramos, J. A., & Fernández-Ruiz, J. J. (1998) · Development · doi:10.1242/dev.125.16.3179 · Cited by 171
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
Marzo, V. D., & Petrocellis, L. D. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 169
Gómez del Pulgar, T., de Ceballos, M. L., Guzmán, M., & Velasco, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205797200 · Cited by 169
Schuel, H., Goldstein, E., Mechoulam, R., Zimmerman, A. M., & Zimmerman, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7678 · Cited by 172
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
Klein, T. W., & Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9007-x · Cited by 172
“…highaffinity ligands strongly supported the existence of cannabinoid receptors (Devane et al. 1988), and the gene for the first of these (CB1) was eventually cloned from brain in 1990 (Matsuda et al. 1990) with a second receptor (CB2) cloned a few years later from immune cells (Munro et al. 1993).”
BackgroundCampos, A. C., & Guimarães, F. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.017 · Cited by 172
Fatty acid amide signaling molecules
Ezzili, C., Otrubova, K., & Boger, D. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.048 · Cited by 160
Spekker, E., Tanaka, M., Szabó, Á., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines10010076 · Cited by 179
Pharmacological Agents Affecting Emesis: A Review (Part I)1
Mitchelson, F. (1992) · Drugs · doi:10.2165/00003495-199243030-00002 · Cited by 172
Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’
Di Marzo, V., & Fontana, A. (1995) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90077-2 · Cited by 170
Nyíri, G., Cserép, C., Szabadits, E., MacKie, K., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.026 · Cited by 161
Sullivan, J. M. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.3.1286 · Cited by 173
Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility
du Plessis, S. S., Agarwal, A., & Syriac, A. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0553-8 · Cited by 160
The Endocannabinoid System of Animals
Silver, R. (2019) · Animals · doi:10.3390/ani9090686 · Cited by 197
Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. H., & Pertwee, R. G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01336-8 · Cited by 171
The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions
Wenger, T., Ledent, C., Csernus, V., & Gerendai, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4977 · Cited by 172
Kinsey, S. G., O'Neal, S. T., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.002 · Cited by 170
Medicinal Cannabis—Potential Drug Interactions
Alsherbiny, M. A., & Li, C. G. (2018) · Medicines · doi:10.3390/medicines6010003 · Cited by 163
Cannabinoid receptors: nomenclature and pharmacological principles
Console-Bram, L., Marcu, J., & Abood, M. E. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.009 · Cited by 162
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
Baumann, M. H., Solis, E., Watterson, L. R., Marusich, J. A., Fantegrossi, W. E., & Wiley, J. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3223-14.2014 · Cited by 186
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
Schlosburg, J. E., Kinsey, S. G., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9075-y · Cited by 165
Cardiovascular Pharmacology of Cannabinoids
Pacher, P., Bátkai, S., & Kunos, G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_20 · Cited by 167
The current state and future perspectives of cannabinoids in cancer biology
Śledziński, P., Zeyland, J., Słomski, R., & Nowak, A. (2018) · Cancer Medicine · doi:10.1002/cam4.1312 · Cited by 159
Molecular and Cellular Mechanisms of Action of Cannabidiol
Naya, N. M., Kelly, J., Corna, G., Golino, M., Abbate, A., & Toldo, S. A. (2023) · Molecules · doi:10.3390/molecules28165980 · Cited by 188
Synergistic interactions of endogenous opioids and cannabinoid systems
Welch, S. P., & Eads, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01908-3 · Cited by 169
Aversive effects of the synthetic cannabinoid CP 55,940 in rats
McGregor, I. S., Issakidis, C. N., & Prior, G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02066-7 · Cited by 168
The use of cannabinoids as anticancer agents
Velasco, G., Hernández-Tiedra, S., Dávila, D., & Lorente, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.010 · Cited by 159
Hernández-Tiedra, S., Fabriàs, G., Dávila, D., Salanueva, Í. J., Casas, J., Montes, L. R., Antón, Z., García-Taboada, E., Salazar-Roa, M., Lorente, M., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1213927 · Cited by 160
An examination of the central sites of action of cannabinoid-induced antinociception in the rat
Martin, W. J., Patrick, S. L., Coffin, P. O., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00195-c · Cited by 165
De Petrocellis, L., Melck, D., Bisogno, T., Milone, A., & Di Marzo, V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00749-0 · Cited by 161
Lee, M.-J., Evans, M., & Hla, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11272 · Cited by 169
Denovan-Wright, E. M., & Robertson, H. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00157-3 · Cited by 169
Ellert-Miklaszewska, A., Kaminska, B., & Konarska, L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.011 · Cited by 165
Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
Hansson, A. C., Bermúdez-Silva, F. J., Malinen, H., Hyytiä, P., Sanchez-Vera, I., Rimondini, R., Rodriguez de Fonseca, F., Kunos, G., Sommer, W. H., & Heilig, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301034 · Cited by 163
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
Rodrı́guez de Fonseca, F., Del Arco, I., Martı́n-Calderón, J. L., Gorriti, M. A., & Navarro, M. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0217 · Cited by 167
Anand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., Korchev, Y., Birch, R., Benham, C., Bountra, C., Chessell, I. P., et al. (2008) · Pain · doi:10.1016/j.pain.2008.06.007 · Cited by 166
“Animal models suggest that they act mainly via non-neuronal cells, possibly inhibition of inflammatory cells in the periphery or CNS, or via release of b-endorphin; however, the clinical relevance and mechanism of analgesic action is uncertain.”
BackgroundInfluentialUeda, N., Tsuboi, K., & Uyama, T. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.02.003 · Cited by 166
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706773 · Cited by 166
Sugars, Sweet Taste Receptors, and Brain Responses
Lee, A. A., & Owyang, C. (2017) · Nutrients · doi:10.3390/nu9070653 · Cited by 191
Identification of a high-affinity binding site involved in the transport of endocannabinoids
Moore, S. A., Nomikos, G. G., Dickason-Chesterfield, A. K., Schober, D. A., Schaus, J. M., Ying, B.-P., Xu, Y.-C., Phebus, L., Simmons, R. M. A., Li, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507470102 · Cited by 165
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
Martin, W. J., Loo, C. M., & Basbaum, A. I. (1999) · Pain · doi:10.1016/s0304-3959(99)00045-7 · Cited by 161
Mazur, A., Lichti, C. F., Prather, P. L., Zielinska, A. K., Bratton, S. M., Gallus‐Zawada, A. E., Finel, M., Miller, G. P., Radominska-p, A., & Moran, J. H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026898 · Cited by 168
Microglia activation states and cannabinoid system: Therapeutic implications
Mecha, M., Carrillo-Salinas, F. J., Feliú, A., Mestre, L., & Guaza, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.011 · Cited by 159
THC and CBD: Similarities and differences between siblings
Stella, N. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.022 · Cited by 186
Fox, S. H., Henry, B., Hill, M., Crossman, A., & Brotchie, J. (2002) · Movement Disorders · doi:10.1002/mds.10289 · Cited by 164
Role of cyclic AMP in the actions of cannabinoid receptors
Childers, S. R., & Deadwyler, S. A. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00419-4 · Cited by 159
Huestis, M. A., Boyd, S. J., Heishman, S. J., Preston, K. L., Bonnet, D., Le Fur, G., & Gorelick, D. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0861-5 · Cited by 167
Adams, I. B., Compton, D. R., & Martin, B. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37342-2 · Cited by 166
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
Oz, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.009 · Cited by 165
Paria, B. C., & Dey, S. K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00197-3 · Cited by 161
Guzmán, M., Sánchez, C., & Galve-Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 161
Metadata
- Authors
- Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Lolait, Stephen J.
- Venue
- Nature
- Published
- 1990-08-09
- Volume
- 346
- Issue
- 6284
- Pages
- 561-564
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075894678
- Cited by
- 5,011
- References
- 20
- Citations by year
- 2026: 47 · 2025: 84 · 2024: 105 · 2023: 141 · 2022: 129 · 2021: 205 · 2020: 185 · 2019: 171 · 2018: 153 · 2017: 169 · 2016: 172 · 2015: 176 · 2014: 184 · 2013: 190 · 2012: 200
- FWCI
- 53.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, G protein-coupled receptors, cDNA cloning, receptor structure, adenylate cyclase inhibition, pertussis toxin sensitivity, cannabis, central nervous system effects, brain mRNA expression
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Binding, Competitive, Cannabinoids, Cell Line, Cerebral Cortex, Cloning, Molecular, Colforsin, Kinetics, Molecular Sequence Data, Receptors, Drug, Transfection, Gene Library, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.